Response to: Comment on ’Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Zhu

Response to: Comment on ’Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Zhu

Saved in:

Bibliographic Details
Main Authors:	Egbert F Smit, Willemijn S M E Theelen, Michiel M Smeenk, Vincent van der Noort, Hanieh Abedian Kalkhoran, Jeroen J M A Hendrikx
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/13/7/e012095.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response to: Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer-a real-world, retrospective bicenter cohort study’ by Wang
by: Egbert F Smit, et al.
Published: (2025-07-01)

Comment on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’
by: Xudong Zhu
Published: (2025-03-01)

Correspondence on ‘Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study’ by Smeenk et al
by: Bi-Cheng Wang
Published: (2025-07-01)

Comparative Analysis of Pembrolizumab Dosing Schedules in the Adjuvant Treatment of Malignant Melanoma
by: Y. Ahmed, et al.
Published: (2024-01-01)

The Problem of Bicenter and Isochronicity for a Class of Quasi Symmetric Planar Systems
by: Du Chaoxiong
Published: (2014-01-01)

Corrigendum to “Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study”
by: Sylvia J. Kroese, et al.
Published: (2022-01-01)

A Probe into "Zhu Bing" in the Dunhuang Manuscripts
by: Yuxiao LIU, et al.
Published: (2025-04-01)

Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer
by: Karen McKinnon, et al.
Published: (2022-02-01)

Combined IVIG and High‐Dose Systemic Corticosteroids for the Management of Pembrolizumab‐Induced Cytokine Release Syndrome in Lung Adenocarcinoma
by: Cheng‐Yin Liu, et al.
Published: (2025-05-01)

User groups of inpatient multidisciplinary therapies for Parkinson’s disease in Germany: a bicenter prospective observational study
by: Vera Tschentscher, et al.
Published: (2025-07-01)

NON-CENTRAL ROLLING OF FLAT WORKS WITH TAPERED THICKNESS
by: I. A. Isaevich, et al.
Published: (2010-11-01)

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma
by: Merve Hasanov, et al.
Published: (2025-12-01)

Non-oscillatory central schemes for the Saint-Venant system
by: Rooholah Abedian
Published: (2025-02-01)

To dose or to let artificial intelligence dose: that is the question!
by: Eduardo Hariton, M.D., M.B.A., et al.
Published: (2025-06-01)

Non-invasive assessment of the effective dose of lamotrigine and topiramate for the treatment of epileptiform states in rats
by: R. G. Paronikyan, et al.
Published: (2019-07-01)

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study
by: Mitchell Emmers, et al.
Published: (2025-05-01)

Extension of Zhu's solution to Lotto's conjecture on the weighted Bergman spaces
by: Abebaw Tadesse
Published: (2004-01-01)

Factors influencing lateral margin diagnosis challenges in Barrett’s esophageal cancer: a bicenter retrospective study in Japan
by: Ippei Tanaka, et al.
Published: (2025-01-01)

Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report
by: Yugo Matsumura, et al.
Published: (2025-01-01)

Dose-dependent effect of coconut oil supplementation on obesity indices: a systematic review and dose-response meta-analysis of clinical trials
by: Zahra Gaeini, et al.
Published: (2025-06-01)

Examples of non-flat bundles of rank one
by: Dan, Ananyo, et al.
Published: (2023-09-01)

A Preliminary Study of the Relevance of Zhu You Shu and Narrative Medicine
by: Qimeng SUN, et al.
Published: (2024-12-01)

Joint variation and ZhuYin dataset for Traditional Chinese document enhancement
by: Shi-Wei Lo, et al.
Published: (2024-11-01)

Air Pollutants Sources in Winter in Chang-Zhu-Tan Region of China
by: Yingfang Zhu, et al.
Published: (2022-01-01)

Dose Selection in Preclinical Studies: Cross-Species Dose Conversion
by: E. V. Shekunova, et al.
Published: (2020-02-01)

Electric field models as a dosing paradigm for TMS in non-motor areas
by: Prem Ganesh, et al.
Published: (2025-01-01)

Early toxicity of high-dose methotrexate in the treatment of non-hodgkin lymphomas in children
by: Z. K. Simavonyan, et al.
Published: (2025-03-01)

Microgravity alleviates low-dose radiation-induced non-targeted carcinogenic effects
by: Yunan Ding, et al.
Published: (2025-06-01)

Role of high-dose chemotherapy with hemopoietic stem cell transplantation in patients with non-Hodgkin's lymphomas
by: V. V. Ptushkin, et al.
Published: (2022-11-01)

Modeling omics dose-response at the pathway level with DoseRider
by: Pablo Monfort-Lanzas, et al.
Published: (2025-01-01)

Correction: Zhu et al. Enhanced DWT for Denoising Heartbeat Signal in Non-Invasive Detection. <i>Sensors</i> 2025, <i>25</i>, 1743
by: Peibin Zhu, et al.
Published: (2025-05-01)

Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
by: Amparo Burgos-San José, et al.
Published: (2021-05-01)

Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
by: Mar Martín-Pérez, et al.
Published: (2019-09-01)

Feasibility of subantimicrobial-dose doxycycline for elbow tendinopathy
by: Brett G. Toresdahl, MD, et al.
Published: (2025-07-01)

Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion
by: Meir Mizrahi, et al.
Published: (2009-01-01)

Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.
by: John A Todd, et al.
Published: (2016-10-01)

A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma
by: Roberto Pili, et al.
Published: (2025-04-01)

Inconsistent TMS dosing in non-motor areas as a key factor in interindividual variability of TMS/EEG responses
by: Brice Passera, et al.
Published: (2025-01-01)

An exact implementation of the generalized Zhang-Zhu criterion for elasto-plastic finite element calculations
by: Lianjin Tao, et al.
Published: (2025-07-01)

Neurotoxicity of high-dose methotrexate in the treatment of non-Hodgkin’s lymphomas in children: clinical and genetic aspects
by: Z. K. Simavonyan, et al.
Published: (2025-05-01)